Loading live market data…

ICON Public Limited Company

NASDAQ:ICLR

$172.08 USD

$4.11 (2.45%)

Volume
454.81K
Average Volume
1.21M
Market Capitalization
$13.18B
P/E Ratio
30.40
Dividend Yield
0.00%
Price Target
$170.00
Year High
$211.00
Year Low
$66.57
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.14
Source Headline
Earnings Preview: Icon PLC (ICLR) Q2 Earnings Expected to Decline

Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-07-15 11:01:10

INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in ICON plc (ICLR) to Contact Law Firm

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Moore Law, PLLC, a shareholder litigation law firm located on Wall Street, is investigating: ICON plc (NASDAQ: ICLR) shareholders should email [email protected] What is the Investigation About ? On February 12, 2026, ICON issued a press release entitled "ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices.

globenewswire.com - 2026-07-09 16:51:00

RESERVOIR ANNOUNCES PUBLISHING DEAL WITH MULTI-PLATINUM AND GRAMMY-WINNING HIP-HOP ICON T.I.

NEW YORK, July 9, 2026 /PRNewswire/ -- Reservoir Media, Inc. (NASDAQ: RSVR, the "Company"), an award-winning independent music company, today announced a publishing deal with hip-hop icon T.I. Under the agreement, Reservoir will work alongside T.I.

prnewswire.com - 2026-07-09 08:00:00

ICON Stock and the CRO Trends Shaping Its Next Growth Phase

ICLR is tapping CRO demand, AI workflows and wider trial access, but uneven revenue trends and margin resets keep its earnings recovery in focus.

zacks.com - 2026-07-08 15:10:19

Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset?

ICON trades below its five-year median, but weaker 2026 guidance, control issues and leverage keep the stock in wait-and-see territory.

zacks.com - 2026-07-07 13:25:53

ICON Stock Outlook 2026 as Margin Woes Meet a Stronger Backlog Base

ICON's stronger bookings and backlog hint at improving demand, but margin pressure, earnings declines and control remediation keep 2026 cautious.

zacks.com - 2026-07-06 15:36:13

ICON Q1 2026: Margins Face Questions, But The Long-Term Thesis Holds

ICON plc delivered a modest 1Q26 beat, with EPS of $2.50 and revenue of $2.03B, but growth was subdued and margins compressed. ICLR reaffirmed FY26 guidance—revenue of $7.85–$8.15B and EPS of $10–$11—signaling management confidence in a back-half recovery. Profitability faced pressure as adjusted EBITDA fell over 20% and margins dropped to 15.6%, driven by business mix and integration costs.

seekingalpha.com - 2026-06-25 06:09:21

Why Icon Stock Crushed it on Wednesday

It posted mixed results, but investors looked past this to other encouraging developments. In particular, this included gross bookings for the period.

fool.com - 2026-06-24 17:02:33

ICON Public Limited Company (ICLR) Q1 2026 Earnings Call Transcript

ICON Public Limited Company (ICLR) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-06-24 13:42:10

ICON Reports First Quarter 2026 Results

DUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2026 Results.

businesswire.com - 2026-06-23 16:15:00

ICON selects Microsoft as a preferred technology partner to power AI-enabled clinical development

DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) today announced that it has selected Microsoft as a preferred technology partner – further advancing ICON's previously announced plan to invest in digital innovation and AI over the next three years. This partnership incorporates an enterprise-wide deployment of Microsoft 365 Copilot along with an enterprise-grade cloud, data and AI infrastructure to further scale Orbis, ICON's secure, governed agentic AI platform. Through Orbis, ICON is building.

businesswire.com - 2026-06-22 07:00:00

ICON Schedules First Quarter 2026 Earnings Conference Call

DUBLIN--(BUSINESS WIRE)--ICON Schedules First Quarter 2026 Earnings Conference Call.

businesswire.com - 2026-06-17 16:15:00

Wells Fargo Named as ICON Preferred Mortgage Lender to Support 3D‑Printed Homes

SAN FRANCISCO--(BUSINESS WIRE)--Wells Fargo announced it has been named a preferred home mortgage lender for ICON, the global leader in advanced construction technologies. The collaboration expands access to financing for buyers of ICON homes and supports broader adoption of innovative construction methods designed to address housing supply and affordability challenges. Through the relationship, Wells Fargo Home Mortgage will offer a 50-basis point lender credit to qualified buyers who finance.

businesswire.com - 2026-06-15 09:00:00

ICON Stock Valuation vs Peers: Is ICLR Cheap Enough?

ICLR looks cheap at 14.7x forward EPS versus peers, but 2026 guidance calls for lower revenue/EPS and a weak margin starting point.

zacks.com - 2026-06-08 12:52:33

ICLR Earnings Reset: What the Accounting Probe Changed

ICON plc details an accounting restatement, flags control weaknesses, and frames 2026 as a reset year amid mix-driven earnings swings.

zacks.com - 2026-06-05 15:10:23

The Cooper Companies (COO) Beats Q2 Earnings and Revenue Estimates

The Cooper Companies (COO) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.1 per share. This compares to earnings of $0.96 per share a year ago.

zacks.com - 2026-06-04 18:45:32

ICON Plc: FY25 Shows Reset Before Reacceleration

ICON plc (ICLR) delivered mixed 4Q25 results: EPS missed by $0.22, but revenue beat by $170M, highlighting margin pressure amid strong demand. FY26 guidance signals a transition year, with revenue expected at $7.85–$8.15B and EPS of $10.00–$11.00, reflecting near-term headwinds and earnings reset. Material weaknesses in internal controls and recent accounting restatements introduce governance concerns, though management is tightening oversight and transparency.

seekingalpha.com - 2026-05-29 07:59:54

ICON Public Limited Company (ICLR) Q4 2025 Earnings Call Transcript

ICON Public Limited Company (ICLR) Q4 2025 Earnings Call Transcript

seekingalpha.com - 2026-05-28 17:04:07

Icon Q4 Earnings Call Highlights

Icon NASDAQ: ICLR executives used the company's latest earnings call to address the results of an accounting investigation, outline fourth-quarter and full-year 2025 performance, and provide guidance for 2026 amid what management described as near-term revenue and margin headwinds.

marketbeat.com - 2026-05-28 10:11:58

Icon PLC (ICLR) Stock Up 4.0% and Still Undervalued -- GF Score: 79/100

On May 27, 2026, Icon PLC (ICLR) shares rose 4.0% today, trading at $118.45. This price action comes within a 52-week range of $66.57 to $211.00. The stock has

gurufocus.com - 2026-05-27 19:26:00

ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation

DUBLIN--(BUSINESS WIRE)--ICON Reports Fourth Quarter and Full Year 2025 Results and Provides Outcome of Audit Committee Investigation.

businesswire.com - 2026-05-27 16:33:00

ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq

DUBLIN--(BUSINESS WIRE)--ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq.

businesswire.com - 2026-05-26 16:05:00

ICON expands US early phase research capabilities with new clinic and outpatient centres

DUBLIN & SAN ANTONIO--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today announced the expansion of its early phase capabilities with the opening of a new, state-of-the-art Clinical Research Unit (CRU) in San Antonio, Texas, as well as new satellite outpatient clinics in Houston, Texas and Lawrence, Kansas. These new, purpose-built clinics will significantly expand ICON's capacity to conduct first-in-human, healthy participant, and patient cohort stu.

businesswire.com - 2026-05-13 08:00:00

Artisan International Value Fund Q1 2026 Portfolio Update

Almost two-thirds of the stocks in the portfolio declined during the quarter, with nearly half falling by more than 10%. Samsung Electronics, the portfolio's largest investment, pre-released its Q1 results, highlighting significant growth in its core semiconductor operations. The equities that had the largest negative impact on the portfolio during the quarter were ICON, Unilever and UBS.

seekingalpha.com - 2026-05-12 06:15:00

A Look at Icon PLC (ICLR) After 4.7% Decline -- GF Value $241.81 vs Price $118.96

On May 11, 2026, Icon PLC (ICLR) shares fell 4.7% today, bringing the current price to $118.96. The stock has traded in a 52-week range between $66.57 and $211.

gurufocus.com - 2026-05-12 00:47:00

Polen International Growth Q1 2026 Portfolio Activity

In Q1 2026, Polen International Growth Portfolio returned -14.4% (net of fees) compared to -0.7% for the Index. We initiated new positions in TSMC, Rheinmetall, Saab, Mitsubishi Heavy Industries, AstraZeneca, AIA Group, Siemens Energy, Samsung Electronics, and Keyence. We sold our holdings in Nintendo, MakeMyTrip, Adidas, Globant, Amadeus IT Group, Monday.com, ICON plc, and HDFC Bank.

seekingalpha.com - 2026-05-10 14:23:00

HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem

Philadelphia, PA, May 05, 2026 (GLOBE NEWSWIRE) -- HealthVerity, Inc., the leader in privacy-protected real-world data exchange and patient identity solutions, today announced that it has entered into a definitive agreement to acquire Symphony Health Solutions Corporation, a commercial healthcare data business formerly part of ICON plc (NASDAQ: ICLR). The transaction is subject to customary closing conditions and is expected to close in May 2026.

globenewswire.com - 2026-05-05 08:00:00

The moon is the ‘ULTIMATE HIGH GROUND': ICON Prime president

President of ICON Prime Will Hurd discusses the company's cutting-edge technology for building permanent moon bases on ‘Maria Bartiromo's Wall Street.' #fox #media #breakingnews #us #usa #new #news #breaking #foxnews #space #nasa #moon #lunar #technology #innovation #economy #science #future #exploration #business #industry #global #infrastructure #engineering #leadership

youtube.com - 2026-05-03 00:00:51

Is Icon PLC (ICLR) a Bargain After 4.8% Drop? GF Value Says Undervalued

On May 01, 2026, Icon PLC (ICLR) shares fell 4.8% to a current price of $112.85. This decline comes amidst a broader trend, as the stock is down 38.1% year-to-d

gurufocus.com - 2026-05-01 17:25:00

ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results

DUBLIN--(BUSINESS WIRE)--ICON Provides Update on Audit Committee Investigation and Timing of Fourth Quarter and Full Year 2025 Financial Results.

businesswire.com - 2026-04-29 07:00:00

ROYAL CARIBBEAN GROUP CONFIRMS ORDER WITH MEYER TURKU FOR ICON 6 AND 7

MIAMI and TURKU, Finland, April 27, 2026 /PRNewswire/ -- Royal Caribbean Group (NYSE: RCL), a global vacation leader redefining the future of vacations, today announced it has confirmed with Meyer Turku the order of a sixth and seventh Icon Class ship to be delivered in 2029 and 2030, respectively. The order is part of the company's long-term framework agreement with Meyer Turku that secures the Group's access to shipbuilding capacity through 2036 and includes the previously announced Icon 5 order to be delivered in 2028.

prnewswire.com - 2026-04-27 19:00:00

Invesco EQV International Equity Fund Q1 2026 Portfolio Review

Invesco EQV International Equity Fund trailed the index primarily due to stock selection in financials and industrials. Stock selection in financials and industrials, along with an underweight and stock selection in energy, detracted the most from relative return. Conversely, an underweight allocation in communication services and stock selection in consumer staples added to relative performance.

seekingalpha.com - 2026-04-26 14:58:00

White Brook Capital Partners: Stocks We Believe Will Be Meaningful Contributors

ICON trades at a low double digit multiple of free cash flow, a fraction of its historical average and a price that materially underestimates the strength of their business. Growth and tumult in private credit, data center financing, and AI driven financial engineering products reinforce the necessity of S&P Global's services. Sanara Medtech continues to be an extremely favorable risk reward with increasing evidence of their product's efficacy recently released and a focus on increasing per hospital doctor penetration.

seekingalpha.com - 2026-04-22 23:59:00

Get ICLR Insider Trade Alerts

ICLR Price Target Summary

Last Month

$184.29

7 analysts

Last Quarter

$160.13

15 analysts

Last Year

$168.83

30 analysts

All Time

$220.58

45 analysts

ICLR Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-06-30 Truist Securities Upgrade Hold Buy
2026-06-26 Mizuho Maintain Outperform Outperform
2026-06-25 Evercore ISI Group Maintain Outperform Outperform
2026-06-25 JP Morgan Maintain Neutral Neutral
2026-06-25 BMO Capital Maintain Outperform Outperform
2026-06-25 B of A Securities Maintain Underperform Underperform
2026-06-25 Baird Maintain Outperform Outperform
2026-06-25 Barclays Maintain Equal Weight Equal Weight
2026-06-25 Citigroup Maintain Neutral Neutral
2026-06-25 RBC Capital Upgrade Sector Perform Outperform
2026-06-25 TD Cowen Maintain Buy Buy
2026-06-24 Barclays Maintain Equal Weight Equal Weight
2026-06-01 B of A Securities Maintain Underperform Underperform
2026-06-01 TD Cowen Maintain Buy Buy
2026-05-29 Citigroup Maintain Neutral Neutral
2026-05-29 BMO Capital Maintain Outperform Outperform
2026-05-29 Barclays Maintain Equal Weight Equal Weight
2026-05-29 JP Morgan Maintain Neutral Neutral
2026-05-29 RBC Capital Maintain Sector Perform Sector Perform
2026-05-29 Truist Securities Maintain Hold Hold
2026-05-18 JP Morgan Maintain Neutral Neutral
2026-03-26 BMO Capital Upgrade Market Perform Outperform
2026-03-11 Citigroup Maintain Neutral Neutral
2026-03-09 Barclays Maintain Equal Weight Equal Weight
2026-02-23 Jefferies Upgrade Hold Buy
2026-02-18 TD Cowen Upgrade Hold Buy
2026-01-22 TD Cowen Maintain Hold Hold
2026-01-08 Truist Securities Downgrade Buy Hold
2025-12-15 Barclays Maintain Equal Weight Equal Weight
2025-10-24 Barclays Maintain Equal Weight Equal Weight
2025-10-24 TD Cowen Maintain Hold Hold
2025-10-02 Barclays Maintain Equal Weight Equal Weight
2025-09-09 Jefferies Downgrade Buy Hold
2025-09-03 Rothschild & Co Upgrade Neutral Buy
2025-09-02 Baird Maintain Outperform Outperform
2025-08-21 Citigroup Downgrade Buy Neutral
2025-07-25 UBS Maintain Buy Buy
2025-07-25 Barclays Maintain Equal Weight Equal Weight
2025-07-25 Mizuho Maintain Outperform Outperform
2025-07-25 Truist Securities Maintain Buy Buy
2025-07-25 Evercore ISI Group Maintain Outperform Outperform
2025-07-24 Baird Upgrade Neutral Outperform
2025-07-09 Evercore ISI Group Maintain Outperform Outperform
2025-05-15 Mizuho Maintain Outperform Outperform
2025-05-02 Goldman Sachs Maintain Neutral Neutral
2025-05-02 Baird Maintain Neutral Neutral
2025-05-02 Barclays Maintain Equal Weight Equal Weight
2025-04-29 JP Morgan Downgrade Overweight Neutral
2025-04-14 TD Cowen Downgrade Buy Hold
2025-04-10 Truist Securities Maintain Buy Buy
2025-04-10 Barclays Downgrade Overweight Equal Weight
2025-04-09 Mizuho Maintain Outperform Outperform
2025-04-07 Citigroup Maintain Buy Buy
2025-03-21 Goldman Sachs Downgrade Buy Neutral
2025-03-04 Baird Maintain Neutral Neutral
2025-02-21 Barclays Maintain Overweight Overweight
2025-02-13 Truist Securities Maintain Buy Buy
2025-02-03 JP Morgan Maintain Overweight Overweight
2025-01-15 RBC Capital Maintain Outperform Outperform
2025-01-14 William Blair Maintain Outperform Outperform
2025-01-06 Citigroup Maintain Buy Buy
2024-12-18 Truist Securities Maintain Buy Buy
2024-11-20 Baird Maintain Neutral Neutral
2024-11-19 Leerink Partners Maintain Outperform Outperform
2024-10-28 Truist Securities Maintain Buy Buy
2024-10-25 JP Morgan Maintain Overweight Overweight
2024-10-25 Baird Maintain Neutral Neutral
2024-10-25 Leerink Partners Maintain Outperform Outperform
2024-10-25 Goldman Sachs Maintain Buy Buy
2024-10-25 Barclays Maintain Overweight Overweight
2024-10-25 TD Cowen Maintain Buy Buy
2024-10-24 Baird Downgrade Outperform Neutral
2024-10-15 Barclays Maintain Overweight Overweight
2024-10-14 Truist Securities Maintain Buy Buy
2024-10-08 Evercore ISI Group Maintain Outperform Outperform
2024-09-20 Baird Maintain Outperform Outperform
2024-09-11 Baird Maintain Outperform Outperform
2024-09-11 Truist Securities Maintain Buy Buy
2024-07-26 Truist Securities Maintain Buy Buy
2024-07-26 Barclays Maintain Overweight Overweight
2024-07-08 Baird Maintain Outperform Outperform
2024-05-31 Baird Maintain Outperform Outperform
2024-05-31 TD Cowen Maintain Buy Buy
2024-04-26 Evercore ISI Group Maintain Outperform Outperform
2024-04-26 TD Cowen Maintain Buy Buy
2024-04-26 Baird Maintain Outperform Outperform
2024-04-04 Mizuho Maintain Buy Buy
2024-04-04 Baird Maintain Outperform Outperform
2024-02-23 Mizuho Maintain Buy Buy
2024-02-23 Truist Securities Maintain Buy Buy
2024-02-23 Evercore ISI Group Maintain Outperform Outperform
2024-02-23 Barclays Maintain Overweight Overweight
2024-01-25 Barclays Maintain Overweight Overweight
2023-12-20 JP Morgan Maintain Overweight Overweight
2023-12-11 Citigroup Maintain Buy Buy
2023-10-17 Baird Maintain Outperform Outperform
2023-09-13 Mizuho Maintain Buy Buy
2023-07-28 Barclays Maintain Overweight Overweight
2023-07-14 Deutsche Bank Maintain Buy Buy
2023-07-11 Mizuho Maintain Buy Buy
2023-05-01 Wells Fargo Maintain Equal Weight Equal Weight
2023-05-01 Baird Maintain Outperform Outperform
2023-04-28 Guggenheim Maintain Buy Buy
2023-04-28 Citigroup Maintain Buy Buy
2023-04-04 Barclays Maintain Overweight Overweight
2023-02-24 Baird Maintain Outperform Outperform
2023-01-20 Guggenheim Maintain Buy Buy
2023-01-17 Barclays Upgrade Equal Weight Overweight
2023-01-13 Barclays Upgrade Equal Weight Overweight
2023-01-12 Baird Maintain Outperform Outperform
2022-11-10 Mizuho Maintain Buy Buy
2022-11-09 B of A Securities Upgrade Neutral Buy
2022-10-10 Guggenheim Maintain Buy Buy
2022-10-06 Barclays Maintain Equal Weight Equal Weight
2022-09-12 Barclays Maintain Equal Weight Equal Weight
2022-09-07 UBS Maintain Buy Buy
2022-08-25 Credit Suisse Maintain Neutral Neutral
2022-07-14 Deutsche Bank Maintain Buy Buy
2022-07-13 Barclays Maintain Equal Weight Equal Weight
2022-07-08 Citigroup Maintain Buy Buy
2022-05-24 Guggenheim Maintain Buy Buy
2022-04-25 Wells Fargo Downgrade Overweight Equal Weight
2022-03-07 Mizuho Maintain Buy Buy
2022-02-25 Deutsche Bank Maintain Hold Hold
2022-02-23 Citigroup Maintain Buy Buy
2022-02-23 Barclays Maintain Equal Weight Equal Weight
2022-01-27 Barclays Maintain Equal Weight Equal Weight
2021-11-05 Mizuho Maintain Buy Buy
2021-11-05 Barclays Maintain Equal Weight Equal Weight
2021-09-27 JP Morgan Upgrade Neutral Overweight
2021-09-14 Jefferies Maintain Buy Buy
2021-07-26 Deutsche Bank Maintain Hold Hold
2021-07-23 Wells Fargo Maintain Overweight Overweight
2021-07-23 Citigroup Upgrade Neutral Buy
2021-07-20 Credit Suisse Maintain Outperform Outperform
2021-05-03 Mizuho Maintain Buy Buy
2021-04-29 Jefferies Maintain Buy Buy
2021-04-29 Credit Suisse Maintain Outperform Outperform
2021-04-01 Wells Fargo Upgrade Equal Weight Overweight
2021-03-08 Baird Upgrade Neutral Outperform
2021-03-03 Barclays Maintain Equal Weight Equal Weight
2021-03-01 UBS Upgrade Neutral Buy
2021-02-26 Truist Securities Upgrade Hold Buy
2021-02-25 Deutsche Bank Maintain Hold Hold
2020-10-23 Truist Securities Maintain Hold Hold
2020-10-23 Mizuho Maintain Buy Buy
2020-10-22 Credit Suisse Maintain Outperform Outperform
2020-07-27 Mizuho Maintain Buy Buy
2020-07-27 Deutsche Bank Maintain Hold Hold
2020-07-27 UBS Maintain Neutral Neutral
2020-07-24 Jefferies Maintain Buy Buy
2020-07-24 B of A Securities Downgrade Buy Neutral
2020-07-23 Credit Suisse Maintain Outperform Outperform
2020-04-24 Baird Maintain Neutral Neutral
2020-04-24 Deutsche Bank Maintain Hold Hold
2020-04-23 Barclays Maintain Overweight Overweight
2020-04-23 Credit Suisse Maintain Outperform Outperform
2020-04-20 Baird Downgrade Outperform Neutral
2020-04-09 Citigroup Maintain Neutral Neutral
2020-03-30 Wells Fargo Maintain Equal Weight Equal Weight
2020-03-26 Barclays Upgrade Equal Weight Overweight
2020-03-23 Jefferies Maintain Buy Buy
2020-03-17 SunTrust Robinson Humphrey Maintain Hold Hold
2020-03-02 Deutsche Bank Maintain Hold Hold
2020-02-21 UBS Maintain Neutral Neutral
2020-02-20 Barclays Maintain Equal Weight Equal Weight
2020-02-20 Mizuho Maintain Buy Buy
2020-01-27 SunTrust Robinson Humphrey Downgrade Buy Hold
2020-01-08 Wells Fargo Maintain Equal Weight Equal Weight
2020-01-07 Citigroup Maintain Neutral Neutral
2019-10-18 UBS Maintain Neutral Neutral
2019-09-23 Keybanc Downgrade Overweight Sector Weight
2019-09-23 KeyBanc Downgrade Overweight Sector Weight
2019-08-08 Keybanc Maintain Overweight Overweight
2019-08-08 KeyBanc Maintain Overweight Overweight
2019-07-26 UBS Upgrade Sell Neutral
2019-07-25 Mizuho Maintain Buy Buy
2019-03-18 Barclays Maintain Equal Weight Equal Weight
2019-02-21 Barclays Maintain Equal Weight Equal Weight
2019-01-25 Mizuho Upgrade Neutral Buy
2018-10-26 Evercore ISI Group Upgrade In Line Outperform
2018-09-11 KeyBanc Maintain Overweight Overweight
2018-09-11 Keybanc Maintain Overweight Overweight
2018-09-11 Baird Maintain Outperform Outperform
2018-06-19 Credit Suisse Maintain Outperform Outperform
2018-06-18 KeyBanc Maintain Overweight Overweight
2018-06-18 Keybanc Maintain Overweight Overweight
2018-04-03 Evercore ISI Group Downgrade Outperform In Line
2018-01-19 Evercore ISI Group Maintain Outperform Outperform
2017-11-13 Keybanc Maintain Overweight Overweight
2017-11-13 KeyBanc Maintain Overweight Overweight
2017-10-27 Barclays Maintain Equal Weight Equal Weight
2017-10-09 Jefferies Maintain Buy Buy
2017-09-11 Bank of America Maintain Buy Buy
2017-07-31 SunTrust Robinson Humphrey Upgrade Hold Buy
2017-06-29 Jefferies Upgrade Hold Buy
2016-12-16 Goldman Sachs Upgrade Neutral Buy
2016-12-16 SunTrust Robinson Humphrey Downgrade Buy Hold
2016-10-14 Evercore ISI Group Upgrade Neutral Buy
2016-07-27 Jefferies Maintain Hold Hold
2016-06-21 Credit Suisse Maintain Outperform Outperform
2016-06-08 Avondale Partners Downgrade Market Perform Market Underperform
2016-06-03 Jefferies Downgrade Buy Hold
2015-10-21 Avondale Partners Maintain Market Perform Perform
2015-07-29 KeyBanc Maintain Overweight Overweight
2015-07-29 Keybanc Maintain Overweight Overweight
2015-07-07 SunTrust Robinson Humphrey Maintain Buy Buy
2015-04-24 Barclays Maintain Equal Weight Equal Weight
2015-03-26 SunTrust Robinson Humphrey Maintain Buy Buy
2015-02-26 Jefferies Maintain Buy Buy
2015-01-28 Jefferies Maintain Buy Buy
2014-10-10 ISI Group Downgrade Strong Buy Neutral
2014-08-04 Credit Suisse Maintain Outperform Outperform
2014-07-31 SunTrust Robinson Humphrey Maintain Buy Buy
2014-07-31 Barclays Maintain Overweight Overweight
2014-07-01 Credit Suisse Maintain Outperform Outperform
2014-05-01 DA Davidson Upgrade Neutral Outperform
2014-03-27 Credit Suisse Maintain Outperform Outperform
2013-10-31 ISI Group Downgrade Strong Buy Buy
2013-10-25 Raymond James Downgrade Strong Buy Outperform
2013-09-17 UBS Maintain Buy Buy
2013-06-11 Sterne Agee Maintain Neutral Neutral
2013-03-12 Jefferies Maintain Buy Buy
2013-02-20 ISI Group Maintain Buy Buy
2013-02-20 Raymond James Upgrade Outperform Strong Buy
2013-02-19 JP Morgan Maintain Neutral Neutral
2013-02-15 Barclays Maintain Overweight Overweight
2013-01-14 Sterne Agee Maintain Neutral Neutral
2013-01-11 Barclays Maintain Overweight Overweight
2012-12-05 Raymond James Downgrade Outperform Market Perform
2012-12-05 Jefferies Maintain Buy Buy
2012-12-04 ISI Group Maintain Overweight Overweight
2012-11-02 Baird Upgrade Neutral Outperform
2012-09-10 Jefferies Upgrade Hold Buy
2012-07-10 ISI Group Maintain Overweight Overweight
2012-04-25 Jefferies Maintain Hold Hold
2012-02-15 Sterne Agee Upgrade Underperform Neutral